Investing

Poverty isn’t pretty. That may sound like an obvious statement, yet I’ve heard some people doubt the benefits of economic...

Over the past decade, investing in biotech stocks with insider buying has tripled the S&P 500’s return. Tandem Diabetes Care (Nasdaq:...

If you’re a trader who’d like to earn higher short-term returns, here’s a tip… Don’t look for bargains in the...

Second quarter earnings season has arrived! Reports start rolling in around July 11 – that’s when the big banks report...

Chief Investment Strategist of Manward Press Shah Gilani is sharing something he’s never discussed before… This includes a bunch of...

Please note that Alexander Green is sending this article out early in honor of Independence Day. The markets and our...

I’ve just returned from The Oxford Club’s two-week Wealth, Wine & Wander Tour to Spain and Portugal. It was one...

Trees don’t grow to the sky. It’s a translation of an old German expression that conveys the idea that there...

The biotech sector tends to attract investors who are interested in exciting new medical advances and drawn to big profits. There are...

When you buy or sell shares of a public company, your actions are almost certainly based on self-interest. You want...